Skip to main content
. 2012 Nov 14;2012(11):CD008653. doi: 10.1002/14651858.CD008653.pub2

24.5. Analysis.

24.5

Comparison 24 Adverse events ‐ febuxostat 240 mg/day versus allopurinol 300 mg/day, Outcome 5 Cardiovascular events (chest pain, coronary artery disease, myocardial infarction, atrial fibrillation).